About
Fate Therapeutics is a clinical-stage biopharmaceutical company developing induced pluripotent stem cell (iPSC)-derived, off-the-shelf cellular immunotherapies, including engineered natural killer (NK) and T cell products, to treat cancer and immune disorders.
Explore Fate Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.